Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

Posted on March 31, 2016 by Vito Di Marco, Vincenza Calvaruso, Donatella Ferraro, Maria Grazia Bavetta, Giuseppe Cabibbo, Elisabetta Conte, Calogero Cammà, Stefania Grimaudo, Rosaria Maria Pipitone, Fabio Simone, Sergio Peralta, Andrea Arini, Antonio Craxì

Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).

This entry was posted in News. Bookmark the permalink.